Document is current

Any future updates will be listed below

Perioperativer Therapieansatz mit Pembrolizumab beim operablen NSCLC II/III

Crossref DOI link: https://doi.org/10.1007/s15033-023-3534-0

Published Online: 2023-09-04

Published Print: 2023-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark